According to a new report from Intel Market Research, Global Pidotimod market was valued at USD 120 million in 2025 and is projected to reach USD 210 million by 2034, growing at a steady CAGR of 6.1% during the forecast period (2026-2034). This growth is driven by increasing prevalence of respiratory infections, rising demand for immunomodulatory therapies, and expanding applications in...